|
|
Expression and Clinical Significance of HIF-1α and VEGF in Oral Cancer Tissues |
HOU Xiao-feng, FENG Wen-zhen |
Department of Stomatology,The Fourth Hospital of Yulin,Xingyuan Hospital,Yulin Shaanxi 719000 |
|
|
Abstract 【Objective】 To investigate the expression and clinical significance of hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in oral cancer tissues. 【Methods】A total of 174 patients with oral cancer who were treated by the Fourth Hospital of Yulin City, Shaanxi Province from May 2014 to February 2016 were selected as the research objects. During the operation, adjacent tissues (>3 cm from the edge of tumor tissue) and cancer tissues were collected. Immunohistochemical method was used to detect the expression of HIF-1α and VEGF in cancer tissues and adjacent tissues of oral cancer patients. General patient data were collected. The relationship of HIF-1α and VEGF expression levels in the cancer tissues of oral cancer patients with the clinicopathological characteristics were analyzed. After 5 years of follow-up, Kaplan-Meier method was used to draw the survival curve, and the Log-rank test was used to test the difference in survival curves of HIF-1α positive vs HIF-1α negative patients, and VEGF positive vs VEGF negative patients. 【Results】The positive rates of HIF-1α and VEGF in cancer tissues of oral cancer patients were higher than those in adjacent tissues (P<0.05). The expression of HIF-1α and VEGF in the cancer tissues of oral cancer patients were related to lymph node metastasis, tumor size, clinical stage, and tumor differentiation (P<0.05), but not related to gender, age, blood vessel invasion, nerve invasion, and location of disease (P>0.05). The 5-year survival rate of HIF-1α-negative patients is higher than that of HIF-1α-positive patients (P<0.05). The median survival time of HIF-1α-negative was 42.63 months, which was longer than that of HIF-1α-positive patients (25.01 months). There was a statistically significant difference between the survival curves of the two population (P<0.05). The 5-year survival rate of VEGF-negative patients was higher than that of VEGF-positive patients (P<0.05). The median survival time of VEGF-negative and VEGF-positive patients was 45.84 months and 16.94 months,respectively, and the difference in survival curves was statistically significant (P<0.05). 【Conclusion】The positive rates of HIF-1α and VEGF in the cancer tissues of patients with oral cancer are relatively higher, which are related to lymph node metastasis, tumor size, clinical stage, and degree of tumor differentiation. The detection of both HIF-1α and VEGF expression can help predict the prognosis in oral cancer patients.
|
Received: 16 February 2022
|
|
|
|
|
[1] ASTHANA S,LABANI S,KAILASH U,et al. Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis[J].Nicotine Tob Res,2019,21(9):1162-1171.
[2] GARREL R,POISSONNET G,MOYA P A,et al. Equivalence randomized trial to compare treatment on the basis of sentinel node biopsy versus neck node dissection in operable T1-T2N0 oral and oropharyngeal cancer[J].J Clin Oncol,2020,38(34):4010-4018.
[3] AGA M,KONDO S,WAKISAKA N,et al. Siah-1 is associated with expression of hypoxia-inducible factor-1alpha in oral squamous cell carcinoma[J].Auris Nasus Larynx,2017,44(2):213-219.
[4] 刘哲,王旖,李蓉,等. 脂肪细胞因子Leptin对体外培养的RF/6A细胞自噬、VEGF表达及细胞增殖、迁移和管腔形成的影响[J].医学临床研究,2022,39(1):1-4.
[5] HWANG-BO J,BAE M G,PARK J H,et al. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model[J].BMC Cancer,2018,18(1):714.
[6] 中华口腔医学会口腔颌面外科专业委员会肿瘤学组. 口腔颌面部恶性肿瘤治疗指南[J].中国实用口腔科杂志,2010,3(7):395-403.
[7] 黄俊辉,李奉华,张凯,等. HPV感染与口腔癌:口腔癌诊疗思路的变革[J].口腔医学研究,2012,28(6):609-611.
[8] LEE L T,WONG Y K,CHAN M Y,et al. The correlation between HIF-1 alpha and VEGF in oral squamous cell carcinomas: Expression patterns and quantitative immunohistochemical analysis[J].J Chin Med Assoc,2018,81(4):370-375.
[9] KUMAR M,NANAVATI R,MODI T G,et al. Oral cancer: Etiology and risk factors: A review[J].J Cancer Res Ther,2016,12(2):458-463.
[10] SIVEEN K S,PRABHU K,KRISHNANKUTTY R,et al. vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges[J].Curr Vasc Pharmacol,2017,15(4):339-351.
[11] 唐欣轶,周辉. 口腔鳞癌组织中ALG-2、HIF-1α和VEGF的表达水平及临床意义[J].解放军医药杂志,2017,29(3):42-45. |
[1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(8): 1273-1275. |
|
|
|
|